英文别名 |
Theliatinib;6ZZ3B7NZ0B;ZB1620;s8584;Pyrrolo(3,4-b)pyrrole-5(1H)-carboxamide, N-(4-((3-ethynylphenyl)amino)-7-methoxy-6-quinazolinyl)hexahydro-1-methyl-, (3aR,6aR)-;(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide;(3aR,6aR)-N-(4-((3-Ethynylphenyl)amino)-7-methoxy-6-quinazolinyl)hexahydro-1-methylpyrrolo(3,4-b)pyrrole-5(1H)-carboxamide;HMPL-309;UNII-6ZZ3B7NZ0B;HY-104066;CHEMBL5314410;AKOS032946520;(3aR,6aR)-N-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole-5-carboxamide;MS-27965;1353644-70-8;SCHEMBL247509;EX-A3179;CS-0027986;HMPL 309;XILIERTINIB [INN];G16819;(3aR,6aR)-N-{4-[(3-ethynylphenyl)amino]-7-methoxyquinazolin-6-yl}-1-methyl-hexahydropyrrolo[2,3-c]pyrrole-5-carboxamide;AC-35865;xiliertinib;XILIERTINIB [WHO-DD];Theliatinib (HMPL-309) |